Australia Proposes Fee Waivers & Faster Generic Drug Registrations To Tackle Shortages
Executive Summary
Australia’s Therapeutic Goods Administration has proposed a range of mechanisms to reduce regulatory burden on companies with the explicit aim of addressing medicines shortages.